This is the authors' abstract. We don't add key points for this paper.
Polypharmacy is common in patients undergoing surgery. This reflects an increasingly older, frail surgical population prescribed medications for multiple long term conditions. Inappropriate management of pre-admission medications has patient safety implications; inappropriate continuation risks cancellations, whereas inappropriate cessation risks postoperative complications or withdrawal. Medications should be continued preoperatively unless the risk of bleeding, thrombosis, infection, anaesthetic interactions or impact of fasting outweighs the benefits of continuation. The evidence base underpinning this is continually evolving, with recent publications suggesting continuation of medications that would historically have been stopped. Perioperative medication optimisation, however, should go beyond simple continuation or cessation of medications. Polypharmacy is independently associated with postoperative complications, longer length of hospital stay and increased readmission. The preoperative period represents an opportunity to reduce these risks by utilising comprehensive geriatric assessment to holistically review patients, optimise long term conditions and deprescribe medications associated with an increased risk of postoperative harm.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Frank et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: